STEMdiff™ Monocyte Kit

For differentiation of human ES and iPS cells to monocytes
STEMdiff™ Monocyte Kit

For differentiation of human ES and iPS cells to monocytes

1 Kit
Catalog # 05320
1,067 USD

INDIVIDUAL COMPONENTS

STEMdiff™ Monocyte Differentiation Supplement (100X)

172 USD
Catalog # 05324
1 x 1 mL

Supplement for the differention to CD14+ monocytes

Required Products
  1. Gentle Cell Dissociation Reagent
    Gentle Cell Dissociation Reagent

    cGMP, enzyme-free cell dissociation reagent

  2. DMEM/F-12 with 15 mM HEPES
    DMEM/F-12 with 15 mM HEPES

    Dulbecco's Modified Eagle's Medium/Nutrient Ham's Mixture F-12 (DMEM/F-12) with 15 mM HEPES buffer

  3. mTeSR™1
    mTeSR™1

    cGMP, feeder-free maintenance medium for human ES and iPS cells

Overview

STEMdiff™ Monocyte Kit includes serum-free media and supplements for the feeder-free differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells to monocytes expressing CD14.

The simple protocol is performed in 2D adherent cultures. During the first 3 days, Medium A induces cells toward mesoderm. For the subsequent 4 days, mesodermal cells are further differentiated toward the hematopoietic lineage using Medium B. At Day 7, the medium is changed to Monocyte Differentiation Medium, which facilitates the differentiation to monocytes. CD14⁺ monocytes can be harvested directly from the culture supernatant starting as early as Day 14 and can be repeatedly harvested during the rest of the culture period. Peak CD14⁺ frequency is typically 60 - 80%.
Advantages
⦁ Serum-free and feeder-free formulation
⦁ Simple monolayer protocol produces monocytes in suspension for easy harvest
⦁ Generation of CD14⁺ monocytes in 14 - 23 days
⦁ Robust generation of monocytes across multiple ES and iPS cell lines
Components
  • STEMdiff™ Hematopoietic Basal Medium, 120 mL
  • STEMdiff™ Hematopoietic Supplement A (200X), 225 μL
  • STEMdiff™ Hematopoietic Supplement B (200X), 225 μL
  • STEMdiff™ Monocyte Differentiation Supplement (100X), 3 x 1 mL (Catalog #05324)
  • StemSpan™ SFEM II, 3 x 100 mL
Subtype
Specialized Media
Cell Type
Dendritic Cells, Macrophages, Monocytes, Myeloid Cells, Pluripotent Stem Cells
Species
Human
Application
Cell Culture, Differentiation, Expansion
Brand
STEMdiff
Area of Interest
Disease Modeling, Immunology, Stem Cell Biology
Formulation
Serum-Free

Scientific Resources

Product Documentation

Document Type Product Name Catalog # Lot # Language
Document Type
Product Information Sheet
Product Name
STEMdiff™ Monocyte Kit
Catalog #
05320
Lot #
All
Language
English
Document Type
Product Information Sheet
Product Name
STEMdiff™ Monocyte Differentiation Supplement (100X)
Catalog #
05324
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Product Name
STEMdiff™ Monocyte Kit
Catalog #
05320
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Product Name
STEMdiff™ Monocyte Kit
Catalog #
05320
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Product Name
STEMdiff™ Monocyte Kit
Catalog #
05320
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Product Name
STEMdiff™ Monocyte Kit
Catalog #
05320
Lot #
All
Language
English
Document Type
Safety Data Sheet 5
Product Name
STEMdiff™ Monocyte Kit
Catalog #
05320
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
STEMdiff™ Monocyte Differentiation Supplement (100X)
Catalog #
05324
Lot #
All
Language
English

Educational Materials (10)

Brochure
Human Monocyte Research Product Workflow
Brochure
Hematopoietic Stem and Progenitor Cells - Products for Your Research
Brochure
Products for Human Pluripotent Stem Cells
Technical Bulletin
Generation of Monocytes from Human Pluripotent Stem Cells Using STEMdiff™ Medium and Supplements
Wallchart
Human Immune Cytokines
Wallchart
Derivation and Applications of Human Pluripotent Stem Cells
Webinar
Online Immunology Journal Club: New Strategies to Target Macrophages in Cancer
30:07
Online Immunology Journal Club: New Strategies to Target Macrophages in Cancer
Webinar
ISSCR Innovation Showcase: Differentiating Immune Cells from Human Pluripotent Stem Cells in Feeder- and Serum-Free Cultures
29:54
ISSCR Innovation Showcase: Differentiating Immune Cells from Human Pluripotent Stem Cells in Feeder- and Serum-Free Cultures
Scientific Poster
An Animal Component-Free, Serum-Free Culture Method for Generation of Human Dendritic Cells
Scientific Poster
A Serum-Free Medium for Differentiation of Monocytes to Macrophages

Product Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Data and Publications

Data

Differentiation of hPSC-Derived CD34+ Cells into CD14+ Monocytes

Figure 1. Monocyte Differentiation Protocol

One day prior to differentiation, human pluripotent stem cell (hPSC) colonies are harvested and seeded as small aggregates (100 - 200 μm in diameter) at 10 - 20 aggregates/cm2 in mTeSR™1, TeSR™-E8™, or mTeSR™ Plus media. After one day, the medium is replaced with Medium A (STEMdiff™ Hematopoietic Basal Medium + Supplement A) to induce mesodermal specification (stage 1). On day 3, the medium is changed to Medium B (STEMdiff™ Hematopoietic Basal Medium + Supplement B) to promote hematopoietic specification (stage 2). On day 7, the medium is replaced with Monocyte Differentiation Medium (StemSpan™ SFEM II + STEMdiff™ Monocyte Differentiation Supplement) to promote the production of CD14+ monocytes (stage 3). Monocyte Differentiation Medium is used for all medium changes for the remaining culture period. CD14+ cells can be detected in suspension starting after day 14, and their frequency gradually increases until day 17 - 23. CD14+ cells can be harvested directly from the culture supernatant during medium changes.

hPSC-Derived CD14+ Monocyte Characterization, Frequency and Yield

Figure 2. Robust and Efficient Generation of CD14⁺ Monocytes Using STEMdiff™ Monocyte Kit

hPSCs were differentiated to monocytes using the 2D culture system described in Figure 1. Between days 17 and 23, cells were harvested every 2 - 3 days and analyzed by flow cytometry for CD14 expression. Representative flow cytometry plots are shown for (A, B) iPS (WLS-1C)-derived cells and (C, D) ES (H9)-derived cells. (E) The average frequency of viable CD14+ monocytes at the peak harvest was 61 - 78%. The average yield of CD14+ monocytes produced per 6-well plate at the peak harvest was between 1.6 x 10^6 and 7.1 x 10^6 cells. Data are shown as mean ± SEM (n = 3 - 14).

Characterization and Phagocytosis Analysis of Macrophages

Figure 3. STEMdiff™ Monocyte Kit Generates Monocytes That Are Capable of Differentiation to Macrophages

hPSC-derived monocytes were harvested after 21 days of culture. These were then differentiated to macrophages using ImmunoCult™-SF Macrophage Medium (Catalog #10961) with 100 ng/mL M-CSF for 4 days. Macrophages were then incubated for an additional 2 days with either 10 ng/mL of LPS and 50 ng/mL of IFN-γ, or 10 ng/mL IL-4, to become polarized to M1 or M2a macrophages, respectively. Representative flow cytometry plots of (A) M1 and (B) M2a macrophages produced from the WLS-1C iPS cell line are shown. (C) To measure phagocytosis, PSC-derived M2a macrophages and peripheral blood (PB) monocyte-derived M2a macrophages (primary M2a macrophages), were incubated with pHrodo™ Red Zymosan A BioParticles® Conjugate and incubated at 37°C for 8 hours. Images were acquired using the IncuCyte® ZOOM every 30 minutes and analyzed for internalization of pHrodo™ Red Zymosan A BioParticles® (measured as red object/mm2). hPSC-derived and primary M2a macrophages show similar phagocytic activity.

Characterization of Dendritic Cells

Figure 4. STEMdiff™ Monocyte Kit Generates Monocytes That Can Be Differentiated to Dendritic Cells

hPSCs were differentiated into monocytes, harvested after 21 days, and differentiated to dendritic cells using ImmunoCult™ Dendritic Cell Culture Kit (Catalog #10985). Half of the dendritic cells were harvested on day 7 and examined for CD14 and CD83 expression to identify CD14⁻CD83⁻/lo immature dendritic cells. The remaining dendritic cells were activated for 2 days and assessed for the presence of CD14⁻CD83⁺ mature dendritic cells at day 7. Representative cultures initiated with ES (H9) cells are shown for production of (A) immature dendritic cells and (B) mature dendritic cells.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.